These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 6970515

  • 1. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T, Jakab L, Fehér J.
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [Abstract] [Full Text] [Related]

  • 2. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T, Jakab L, Fehér J, Cseh K.
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [Abstract] [Full Text] [Related]

  • 3. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R, Many A, Ramot B, Trainin N.
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
    Pozsonyi T, Fehér J, Jakab L.
    Allergol Immunopathol (Madr); 1981 Jan; 9(1):37-44. PubMed ID: 6973266
    [Abstract] [Full Text] [Related]

  • 5. The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report.
    Gordon BL, Keenan JP.
    Ann Allergy; 1975 Dec; 35(6):343-55. PubMed ID: 1081857
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rosenthal M, Trabert U, Müller W.
    Clin Exp Immunol; 1976 Sep; 25(3):493-6. PubMed ID: 1085681
    [Abstract] [Full Text] [Related]

  • 8. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V, Vangelista A, Frascà GM, Nanni-Costa A, Borgnino LC.
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [Abstract] [Full Text] [Related]

  • 9. [Serum factors inhibiting cellular immunity in systemic lupus erythematosus].
    Lavalle C, Alcocer J, Gudiño J, Fraga A.
    Prensa Med Mex; 1978 Sep; 43(1-2):16-20. PubMed ID: 309127
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Diagnosis of T-immunodeficiencies in lupus erythematosus and patient treatment with levamisole].
    Shaposhnikov OK, Gorbunov VF.
    Vestn Dermatol Venerol; 1979 Mar; (3):3-6. PubMed ID: 311566
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM, Sakharchuk VM, Lysenko GI.
    Ter Arkh; 1981 Mar; 53(7):121-4. PubMed ID: 6457406
    [No Abstract] [Full Text] [Related]

  • 13. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
    Messner RP, Lindström FD, Williams RC.
    J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
    [Abstract] [Full Text] [Related]

  • 14. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI, Lukach EV, Krivokhatskaia LD.
    Eksp Onkol; 1988 Dec; 10(3):54-7. PubMed ID: 2970382
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cloning of T-lymphocytes in systemic lupus erythematosus.
    Whittingham S, Rodger B, Matthews JV, Mackay IR.
    Clin Exp Immunol; 1978 Oct; 34(1):63-8. PubMed ID: 312168
    [Abstract] [Full Text] [Related]

  • 17. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
    Basch CM, Spitler LE, Engleman EG, Engleman EP.
    J Rheumatol; 1977 Oct; 4(4):377-88. PubMed ID: 604477
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
    Stanislav ML, Balabanova RM, Nikonova MF, Litvina MM, Iarilin AA.
    Ter Arkh; 2000 Oct; 72(5):44-9. PubMed ID: 11109620
    [Abstract] [Full Text] [Related]

  • 20. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y, Rotter V, Ramot B.
    Biomedicine; 1975 Jun 30; 23(6):198-200. PubMed ID: 1082352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.